arrow
H

Heidi M. Ferguson

merck & company
H指数:14
被引数:721

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

STimulator of INterferon Genes Agonism Accelerates Antitumor Activity in Poorly Immunogenic Tumors
2022-02-088
OA
Sonoporation-Enhanced Delivery of STING Agonist Induced Robust Immune Modulation and Tumor Regression

声穿孔增强STING激动剂的递送诱导强大的免疫调节和肿瘤消退

2021-08-245
OAAI
Combination of EP4 antagonist MF-766 and anti-PD-1 promotes anti-tumor efficacy by modulating both lymphocytes and myeloid cells
2021-03-1840
OAAI
Carbamate and N-Pyrimidine Mitigate Amide Hydrolysis: Structure-Based Drug Design of Tetrahydroquinoline IDO1 Inhibitors
2021-02-2617
OA
Discovery of Potent and Orally Available Bicyclo[1.1.1]pentane-Derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors

发现有效且可口服的双环 [1.1.1] 戊烷衍生的Indoleamine-2,3-双加氧酶1 (IDO1) 抑制剂

2020-07-1557
OAAI
Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases
2020-01-0920
OAAI
Discovery of Amino-cyclobutarene-derived Indoleamine-2,3-dioxygenase 1 (IDO1) Inhibitors for Cancer Immunotherapy

发现用于癌症免疫疗法的氨基-环丁基芳烃衍生的Indoleamine-2,3-双加氧酶1 (IDO1) 抑制剂

2019-09-1838
OAAI
Inhibition of RORγT Skews TCRα Gene Rearrangement and Limits T Cell Repertoire Diversity

抑制ror γ T使tcr α 基因重排偏斜并限制T细胞库多样性

2016-12-0153
OAAI